Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Technologies Regulatory News (BIG)

Share Price Information for Big Technologies (BIG)

Share Price is delayed by 15 minutes
Get Live Data
104.50    0.00 (0.00%)
Bid:
101.50
Ask:
104.50
Spread: 3.00 (2.956%)
Market Cap: £305.38m
BIG Live PriceLast checked at - London Stock Exchange

Intraday Big Technologies Share Chart

AGM Statement

27 May 2022 07:00

RNS Number : 9787M
Big Technologies PLC
27 May 2022
 

27 May 2022

 

Big Technologies plc

("Big Technologies" or the "Company" and the "Group")

AGM Statement

 

Big Technologies plc, the UK-based, remote people monitoring technology company, will hold its first Annual General Meeting in London later today.

At the meeting, Simon Collins, Chairman of Big Technologies plc will make the following statement for the four months ended April 2022.

 

Following our initial public offering in July 2021, I am pleased to report that the team at Big Technologies has adjusted well to life as a listed business and we are confident in the future prospects for the Group. Our customers, suppliers, employees and shareholders have all benefitted from our listing, which brings increased disclosure, scale, financial strength and flexibility.

We have made good progress so far in 2022, continuing to increase the number of individuals that we track around the globe and expanding into new territiories. The pipeline of future opportunities remains strong and we expect to convert new customers to our products and services, steadily increasing our market share.

We continue to work hard to overcome the well documented global supply chain challenges and have increased our levels of inventory to secure certain long lead-time components. As we grow, the increasing cost efficiencies in our SaaS-like delivery model have enabled us to improve operating profit margins offsetting the inflation that we see in our manufacturing costs.

In the four months ending April 2022, we have recorded unaudited consolidated revenue of £13.9 million, an increase of 18% versus the same period in 2021. Monthly Recurring Revenue in April 2022 was £3.9 million and net cash as at 30 April 2022 increased to £52.6 million. These positive trends lead the Board to remain confident in the Group's ability to deliver results at least in line with current market expectations(1).

We believe that our products and technology deliver benefits for society across the globe. In the criminal justice sector our products facilitate a shift towards rehabilitative community-based sentencing which reduces recidivism and keeps communites safer. In the care sector our technology helps people live happier, healthier and more independent lives.

Our business has a clear strategy and strong values which underpin everything that we do. Our systems are trusted the world over to make a tangible difference to people's lives and we look forward to the next few years with confidence.

(1) Latest company compiled view of market expectations show adjusted EBITDA of £25.0 to £25.5 million (stated before share-based payments expense).

 

For further information please contact:

 

Big Technologies

+44 (0) 19 2360 1910

Sara Murray (Chief Executive Officer)

Daren Morris (Chief Financial Officer)

Zeus (Nominated Adviser and Sole Broker)

+44 (0) 20 3829 5000

Jamie Peel / Dan Bate / Kieran Russell (Investment Banking)

Benjamin Robertson (Equity Capital Markets)

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMSEIFLMEESEDI
Date   Source Headline
11th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20242:47 pmRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSDirector/PDMR Shareholding
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20248:13 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:01 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSDirector/PDMR Shareholding
1st Oct 20247:00 amRNSDirector/PDMR Shareholding
27th Sep 20247:00 amRNSShare Buyback Programme
25th Sep 20247:00 amRNSHalf-year Report
23rd Aug 20247:00 amRNSEBT Share Purchase and Share Transfer
22nd Aug 202410:38 amRNSDirector/PDMR Shareholding
21st Aug 20248:00 amRNSEBT Share Transfer
8th Aug 202411:40 amRNSDirector/PDMR Shareholding
5th Aug 20247:00 amRNSDirector/PDMR Shareholding
19th Jul 202410:36 amRNSNon-Executive Chair to step down
11th Jun 20242:49 pmRNSDirector/PDMR Shareholding
7th Jun 202412:27 pmRNSHolding(s) in Company
5th Jun 20243:53 pmRNSDirector/PDMR Shareholding
29th May 20247:00 amRNSResult of AGM
28th May 20247:00 amRNSAGM Statement
20th May 202411:18 amRNSHolding(s) in Company
26th Apr 202411:28 amRNS2023 Annual Report and Notice of AGM
26th Mar 20247:00 amRNS2023 Preliminary audited results
22nd Feb 202411:35 amRNSHolding(s) in Company
5th Feb 20244:25 pmRNSDirector/PDMR Shareholding
29th Jan 20247:05 amRNSResponse to press speculation
26th Jan 202411:07 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSEBT Share Purchase
23rd Jan 20247:00 amRNSDirector/PDMR Shareholding
22nd Jan 20242:23 pmRNSDirector/PDMR Shareholding
22nd Jan 202412:12 pmRNSHolding(s) in Company
19th Jan 20247:04 amRNSTrading Statement
22nd Dec 202311:30 amRNSHolding(s) in Company
21st Dec 20231:35 pmRNSEBT Share Purchase
20th Dec 20232:16 pmRNSDirector/PDMR Shareholding
8th Dec 20233:05 pmRNSDirector/PDMR Shareholding
8th Dec 20237:00 amRNSEBT Share Purchase
6th Dec 20232:06 pmRNSEBT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.